Abstract

Despite the enormous progress and development of modern therapies, lung cancer remains one of the most common causes of death among men and women. The key element in the development of new anti-cancer drugs is proper planning of the preclinical research phase. The most adequate basic research exemplary for cancer study are 3D tumor microenvironment in vitro models, which allow us to avoid the use of animal models and ensure replicable culture condition. However, the question tormenting the scientist is how to choose the best tool for tumor microenvironment research, especially for extremely heterogenous lung cancer cases. In the presented review we are focused to explain the key factors of lung cancer biology, its microenvironment, and clinical gaps related to different therapies. The review summarized the most important strategies for in vitro culture models mimicking the tumor–tumor microenvironmental interaction, as well as all advantages and disadvantages were depicted. This knowledge could facilitate the right decision to designate proper pre-clinical in vitro study, based on available analytical tools and technical capabilities, to obtain more reliable and personalized results for faster introduction them into the future clinical trials.

Highlights

  • Cancer is a leading disease in mortality worldwide

  • The aim of this paper is to summarize the main directions in three-dimensional (3D) culturing technologies with the aim of solving challenges from lung cancer diagnosis and treatment

  • Lung cancer is classified in two main subgroups: non-small cell lung cancer (NSCLC) and small-cell lung cancer (SCLC)

Read more

Summary

Introduction

Cancer is a leading disease in mortality worldwide. Tremendous progress in cancer diagnostic and therapies has been made in the past years. Singlecell transcriptomic analysis of biopsy samples collected from patients with NSCLC in the III/IV disease stage showed significant differentiation in cellular regulation processes, molecular tumor development, and cell phenotype. On the basis of reports about high variability of tumors’ genetic, molecular, and phenotyping profiles amongst patients with the same histopathological cancer type, there is still a necessity to uncover the mechanisms of interaction between tumors and TME’s compartments, improving highly precise basial research with the potential for use in clinical practice [22,23,24]. We analyze the main challenges in the field of lung cancer research, taking into account the key features of tumor–microenvironment interactions and technical possibilities for providing in vitro 3D tumor microenvironments for lung cancer cultures

Lung Cancer Origin
Immunology of Lung Cancer Tumor
The Origin of Used Tumor Cells
Hydrogel Based Technics
Challenges in Lung Cancer Diagnostic and Treatment
Radio- and Chemotherapy
Targeted Therapy
Immunotherapy
Findings
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call